Comparison Between Effect of Vitamin D Versus Dexmedetomidine in Patients with Head Trauma Using Interleukin 6
NCT06565338 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2024-11-04
Summary
in this study the investigators compare between the neuroprotective effect of vitamin d versus dexmedetomidine in patients with traumatic brain injury using interleukin 6 as inflammatory biomarker
Conditions
Interventions
- DRUG
-
Dexmedetomidine
drug
- DRUG
-
Vitamin D3
drug
Sponsors & Collaborators
-
Minia University
lead OTHER
Principal Investigators
-
ahmed ezz · Minia University
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-04-25
- Primary Completion
- 2023-12-25
- Completion
- 2024-02-05
- FDA Drug
- Yes
Countries
- Egypt
Study Locations
More Related Trials
-
Effect of Dexmedetomidine on Brain Homeostasis and Neurocognitive Outcome
NCT04266665 ·Status: COMPLETED ·Phase: PHASE4
-
Scalp Infiltration With Dexamethasone Plus Ropivacaine for Post-craniotomy Pain
NCT04488315 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Clinical Analysis of Early Hormones Between Patients With Traumatic Brain Injury and Cerebral Hemorrhage
NCT06221215 ·Status: RECRUITING
-
The Relationship Between Lipid Peroxidation Products From Traumatic Brain Injury and Secondary Coagulation Disorders
NCT04274777 ·Status: UNKNOWN
-
Creatine Monohydrate for Mild Traumatic Brain Injury: a Randomised Controlled Pilot Study
NCT06644131 ·Status: COMPLETED ·Phase: NA
-
The Use of Anti-oxidants to Reduce Sequela of Mild Traumatic Brain Injury (mTBI) After Blast Exposure
NCT00822263 ·Status: COMPLETED ·Phase: NA
-
Effect of Progesterone Therapy on Traumatic Subarachinoid Haemorrhage on Clinical Outcome and Resistive Vasculer Indices of Middle Cerebral Artery Transcranial Doppler
NCT04426487 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Adding Dexmedetomidine to Mannitol to Attenuate the Increase of Intracranial Pressure
NCT07064720 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effects of Intranasal Nerve Growth Factor for Traumatic Brain Injury
NCT01212679 ·Status: COMPLETED ·Phase: PHASE2
-
Vitamin Therapy in Concussion Management: A Randomized Control Trial
NCT02382679 ·Status: TERMINATED ·Phase: NA
-
Normothermia in Patients With Acute Cerebral Damage
NCT00491192 ·Status: UNKNOWN ·Phase: PHASE4
-
Nebulized Dexmedetomidine Versus Oral Sumatriptan in Treatment of Post Dural Puncture Headache in Cesarean Section
NCT06514040 ·Status: COMPLETED ·Phase: NA
-
Traumatic Brain Injury and the Gut Microbiome
NCT04949607 ·Status: COMPLETED ·Phase: NA
-
Impact of Amantadine on Traumatic Brain Injury
NCT04527289 ·Status: COMPLETED ·Phase: PHASE4
-
Dexmedetomidine and Subarachnoid Haemorrhage
NCT01664520 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effects of Intravascular Administration of Mesenchymal Stromal Cells Derived from Wharton's Jelly of the Umbilical Cord on Systemic Immunomodulation and Neuroinflammation After Traumatic Brain Injury.
NCT06146062 ·Status: RECRUITING ·Phase: PHASE2
-
Intravenous Exenatide in Patients With Acute Brain Injury
NCT02058940 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Mannitol Volume with Changes in Osmolarity in Traumatic Brain Injury
NCT06846307 ·Status: COMPLETED ·Phase: PHASE3
-
Mgt of Chronic Subdural Hematoma Using Dexamethasone
NCT02938468 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Effect of Progesterone Administration on Severely Head Injured Patients
NCT06631547 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Evaluating the Effect of Tranexamic Acid on the Clinical Outcomes in Patients With Traumatic Brain Injury
NCT06330935 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Serum and Urine Ghrelin in Adult Epileptic Patients
NCT03926273 ·Status: COMPLETED
-
Vitamin B12 vs B3 for Nerve Regeneration and Functional Recovery After Pediatric Traumatic Brain Injury
NCT05958277 ·Status: COMPLETED ·Phase: PHASE3
-
Deferoxamine and Xingnaojing Injection Treatment in Intracerebral Hemorrhage
NCT02367248 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Effects of Dexmedetomidine on Inflammatory Cytokines in Patients With Aneurysmal Subarachnoid Hemorrhage
NCT01565590 ·Status: TERMINATED ·Phase: PHASE3